We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IDRSF market cap is 152.75M. The company's latest EPS is CHF -1.5799 and P/E is -0.51.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 23.82M | 71.76M | 35.35M | 97.1M | 152.39M |
Operating Income | -482.42M | -410.58M | -613M | -802.96M | -560.24M |
Net Income | -493.61M | -444.79M | -634.6M | -827.9M | -297.92M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 1B | 1.44B | 1.48B | 904.18M | 500M |
Total Liabilities | 839.85M | 849.88M | 1.38B | 1.57B | 1.47B |
Total Equity | 164.35M | 585.48M | 104.2M | -660.96M | -968.72M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | -462.04M | -364.67M | -589.9M | -859.11M | -629.3M |
Investing | -74.81M | -607.13M | -53.26M | 743.9M | 632.61M |
Financing | 1.33M | 850.08M | 604.15M | 162.31M | -197k |
Market Cap | 152.75M |
Price to Earnings Ratio | -0.51 |
Price to Sales Ratio | 1 |
Price to Cash Ratio | 1.05 |
Price to Book Ratio | -0.16 |
Dividend Yield | - |
Shares Outstanding | 188.57M |
Average Volume (1 week) | 200 |
Average Volume (1 Month) | 1.68k |
52 Week Change | -67.21% |
52 Week High | 2.88 |
52 Week Low | 0.81 |
Spread (Intraday) | 0 (0%) |
Company Name | Idorsia AG (CE) |
Address |
hegenheimermattweg 91 allschwil 4123 |
Website | https://www.idorsia.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions